Evidence map›Paper›PMID 37580790›Full record

ReviewCell & bioscience2023

New insights into the important roles of phase seperation in the targeted therapy of lung cancer.

Ying Zou, Hongmei Zheng, Yue Ning, Yang Yang, Qiuyuan Wen, Songqing Fan

Open access · goldAbstract readReview
In one paragraph

Review in Cell & bioscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. CircDNA2-Educated YTHDF2 Phase Separation Promotes PMAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Transcription regulation by biomolecular condensates.Nature reviews. Molecular cell biology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ying ZouDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Hongmei ZhengDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Yue NingDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Yang YangDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Qiuyuan WenDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Songqing FanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. songqingfan@csu.edu.cn.
Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

Innovation-Driven Project of Central South University 2023ZZTS0843National Natural Science Foundation of China 81703009National Natural Science Foundation of China 81773218National Natural Science Foundation of China 81972838National Natural Science Foundation of China 82102805National Natural Science Foundation of China 82272722Natural Science Foundation of Hunan Province 2017JJ3457Natural Science Foundation of Hunan Province 2020JJ4122Natural Science Foundation of Hunan Province 2021JJ30904Natural Science Foundation of Hunan Province 2021JJ40890
6 · The paper itself

Abstract

Lung cancer is a complex and heterogeneous disease characterized by abnormal growth and proliferation of lung cells. It is the leading cause of cancer-related deaths worldwide, accounting for approximately 18% of all cancer deaths. In recent years, targeted therapy has emerged as a promising approach to treat lung cancer, which involves the use of drugs that selectively target specific molecules or signaling pathways that are critical for the growth and survival of cancer cells. Liquid-liquid phase separation (LLPS) is a fundamental biological process that occurs when proteins and other biomolecules separate into distinct liquid phases in cells. LLPS is essential for various cellular functions, including the formation of membraneless organelles, the regulation of gene expression, and the response to stress and other stimuli. Recent studies have shown that LLPS plays a crucial role in targeted therapy of lung cancer, including the sequestration of oncogenic proteins and the development of LLPS-based drug delivery systems. Understanding the mechanisms of LLPS in these processes could provide insights into new therapeutic strategies to overcome drug resistance in lung cancer cells.

Indexed as

EGFRLiquid–liquid phase separationNSCLCTargeted therapyYAP

Identifiers

PMID37580790
PMCPMC10426191
OpenAlexW4385801326

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.